Updated on 30 October 2026
Partner for Healthcare Software, AI & Data Integration
Marketing Specialist at BioSistemika d.o.o.
Ljubljana, Slovenia
About
BioSistemika is seeking opportunities to join Horizon Europe Cluster 1 (Health) consortia as a technical R&D partner for the 2027 calls.
We are a Slovenian SME specializing in custom software development and digitalization for healthcare, life sciences, biotechnology, pharmaceuticals, diagnostics, and medical devices.
Founded in 2010, our interdisciplinary team of more than 40 software engineers, scientists, and domain experts delivers end-to-end digital solutions, from requirements analysis and software architecture to development, integration, testing, validation, and long-term maintenance.
Our expertise and potential contributions
We can contribute to Horizon Europe Health projects in the following areas:
-
Diagnostic and medical-device software: Software for point-of-care and connected diagnostic devices, data acquisition, signal processing, result interpretation, reporting, and integration with laboratory and healthcare systems.
-
AI-enabled applications and scientific data platforms: Predictive analytics, biomarker discovery, integration of AI/ML models, clinical decision-support applications, data harmonization, visualization, and FAIR data management.
-
Health data integration and interoperability: Secure and scalable data architectures, integration of laboratory instruments and existing information systems, and interoperable workflows for sensitive health data.
-
Laboratory automation and biomanufacturing: Software for high-throughput laboratory workflows, instrument integration, experiment management, process monitoring, and quality control.
-
Regulatory compliance, validation, and cybersecurity: Support for MDR, IVDR, EU AI Act, IEC 62304, ISO 13485, ISO 14971, GDPR, software validation, risk management, audit trails, and data traceability.
Horizon Europe Cluster 1 calls of interest
We are particularly interested in joining consortia preparing proposals for the following 2027 topics:
-
HORIZON-HLTH-2027-01-IND-01: Development of cell-free protein synthesis platforms for discovery and/or production of biologicals.
-
HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response using AI methodologies for chronic non-communicable diseases.
-
HORIZON-HLTH-2027-02-IND-02-two-stage: Portable and versatile point-of-care diagnostics.
-
HORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis.
Potential roles in a consortium
Depending on project needs, BioSistemika can participate as:
-
Work-package leader or co-leader for software development, digitalization, and AI-enabled applications.
-
Task leader for laboratory and medical-device connectivity, data integration, and software architecture.
-
Technology partner developing analytical, predictive, and decision-support software.
-
Regulatory and compliance contributor supporting software validation, risk management, traceability, and cybersecurity.
-
Long-term software development partner delivering maintainable and scalable software solutions beyond the funded project.
-
Subcontractor for clearly defined software development, integration, testing, validation, or consulting activities.
Experience in European R&D projects
BioSistemika has extensive experience in competitive European and national R&D programmes, including Horizon Europe, Horizon 2020, EIC Pathfinder, EIC Accelerator, Eurostars, and Eureka.
Selected projects include:
-
PEARL-DNA (EIC Pathfinder) – Coordinator
-
RAPID-COVID (IMI/H2020) – Partner
-
GeneH (Horizon Europe) – Partner
-
DATANA (EIC Accelerator) – Single participant
-
GuarDNA (Eurostars) – Coordinator
-
Auto3dMSC (Eureka) – Partner
We bring technical expertise, experience in collaborative R&D projects, and the ability to translate research requirements into practical, reliable software solutions.
Let's connect
We are open for discussions with consortium coordinators, universities, research organizations, hospitals, healthcare providers, medical-device manufacturers, and technology partners seeking software development and digitalization expertise for Horizon Europe Cluster 1 proposals.
Contact: grants@biosistemika.com
Website: https://biosistemika.com/
Topic
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
- Destination 6: HORIZON-HLTH-2027-01-IND-01: Development of cell-free protein synthesis platforms for discovery and/or production of biologicals
- Destination 6: HORIZON-HLTH-2027-02-IND-02-two-stage: Portable and versatile Point-of-care diagnostics
- Destination 5: HORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
Type
- Partner seeks Consortium/Coordinator
Attached files
Organisation
Similar opportunities
Project cooperation
- Partner seeks Consortium/Coordinator
- Destination 6: HORIZON-HLTH-2027-02-IND-02-two-stage: Portable and versatile Point-of-care diagnostics
- Destination 5: HORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Michela Mattaloni
Innovation Unit Coordinator | EU Funding Manager at Datawizard Srl
Rome, Italy
Project cooperation
- Partner seeks Consortium/Coordinator
- Destination 5: HORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
- Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Michela Mattaloni
Innovation Unit Coordinator | EU Funding Manager at Datawizard Srl
Rome, Italy
Project cooperation
Non-invasive gynaecological biomarkers and diagnostics (GyLDa platform), focus on endometriosis
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Cristina Vilarmau
Head of Business Development & Innovation at Mimark Diagnostics S.L
Barcelona, Spain